Coincidence of multiple sclerosis and myasthenia gravis
Authors:
P. Hemerková 1; H. Matulová 1; J. Jandura 2
Authors‘ workplace:
Neurologická klinika LF UK a FN Hradec Králové
1; Radiologická klinika LF UK a FN Hradec Králové
2
Published in:
Cesk Slov Neurol N 2020; 83/116(6): 649-651
Category:
Letter to Editor
doi:
https://doi.org/10.48095/cccsnn2020649
Sources
1. Vachová M. Současná epidemiologická data roztroušené sklerózy v ČR. Cesk Slov Neurol N 2010; 73/106 (Suppl 2): S124.
2. Piťha J. Klinický obraz myasthenia gravis. In: Piťha J (ed). Myasthenia gravis a ostatní poruchy nervosvalového přenosu. Praha: Maxdorf 2010: 96–114.
3. Špalek P. Myasténia gravis. Cesk Slov Neurol 2008; 71/104 (1): 7–24.
4. Jakubíková M., Piťha J. Současný pohled na imunopatogenezi myasthenia gravis. Cesk Slov Neurol N 2015; 78/111 (6): 649–654.
5. Dehbashi S, Hamouda D, Shanina E. Co-occurrence of multiple sclerosis and myasthenia gravis: a case report and review of immunological theories. Mult Scler Relat Disord 2019; 34: 135–136. doi: 10.1016/j.msard.2019.06.027.
6. Danikowski KM, Jayaraman S, Prabhakar BS. RegulatoryT cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation 2017; 14 (1): 117. doi: 10.1186/s12974-017-0892-8.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2020 Issue 6
Most read in this issue
- Progressive supranuclear palsy
- Suprascapular neuropathy
- Flexible endoscopic evaluation of swallowing vs. screening tests for dysphagia and their effect on the final outcome in post-acute stroke patients
- COVID-19 associated encephalopathy responding to treatment with intravenous immunoglobulins